NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
Showing 1-20 of 39 articles
Coronary interventions
Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients August 25, 2020 | 10.4244/EIJ-D-20-00749
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial
June 25, 2020 | 10.4244/EIJ-D-19-00851
Coronary interventions
Diagnostic Performance of Angiography-based Fractional Flow Reserve in Various Subgroups: Report from the FAST-FFR Study May 4, 2020 | 10.4244/EIJ-D-19-00933
Coronary interventions
The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database January 17, 2020 | 10.4244/EIJ-D-19-00467
Will the PARTNER 3 Low Risk Trial change my practice?
December 20, 2019 | 10.4244/EIJ-D-19-00847
Coronary interventions
Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial December 3, 2019 | 10.4244/EIJ-D-19-00686
Heart Team 2.0
November 15, 2019 | 10.4244/EIJV15I10A155
Interventions for heart failure
Pulmonary artery denervation using catheter-based ultrasonic energy October 18, 2019 | 10.4244/EIJ-D-18-01082
Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
August 9, 2019 | 10.4244/EIJ-D-19-00262
Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement
June 20, 2019 | 10.4244/EIJ-D-18-00954
Coronary interventions
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial November 20, 2018 | 10.4244/EIJ-D-18-00711
Interventions for valvular disease
Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model July 20, 2018 | 10.4244/EIJ-D-18-00032
Interventions for valvular disease
Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies March 20, 2018 | 10.4244/EIJ-D-17-00704
Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions
December 8, 2017 | 10.4244/EIJ-D-16-00216
Interventions for valvular disease
Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration September 24, 2017 | 10.4244/EIJ-D-17-00509
Coronary interventions
Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES) November 20, 2016 | 10.4244/EIJV12I10A200
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial September 18, 2016 | 10.4244/EIJV12I7A141
Interventions for valvular disease
Upcoming TAVI trials: rationale, design and impact on clinical practice September 18, 2016 | 10.4244/EIJV12SYA12
Coronary interventions
In vivo delivery and long-term tissue retention of nano-encapsulated sirolimus using a novel porous balloon angioplasty system August 20, 2016 | 10.4244/EIJY15M10_01
Coronary interventions
Will LEADERS-FREE change my practice? A randomised double-blind comparison of the BioFreedom™ drug-coated stent vs. the Gazelle™ bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy August 20, 2016 | 10.4244/EIJV12I6A129